| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Physiology, National University of Singapore, Singapore
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Recently, it has become clear that sphingolipids are sources of important signaling molecules. Particularly, the sphingolipid metabolites, ceramide and sphingosine-1-phosphate (S1P), have emerged as a new class of potent bioactive molecules, implicated in a variety of cellular processes such as cell differentiation, apoptosis, and proliferation (16, 17, 18, 19). Interest in S1P focused recently on two distinct cellular actions of this lipid, namely its function as an extracellular ligand activating specific GPCRs and its role as an intracellular second messenger (20). Several findings enforced the notion of S1P as an important intracellular second messenger. First, activation of various plasma membrane receptors, such as the platelet-derived growth factor receptor (21, 22), the Fc
RI and Fc
RI Ag receptors (23, 24, 25), as well as the fMLP receptor (26), was found to rapidly increase intracellular S1P production through the stimulation of the SPHK. Second, inhibition of SPHK stimulation strongly reduced or even prevented cellular events triggered by these receptors, such as receptor-stimulated DNA synthesis, Ca2+ mobilization, and vesicular trafficking (21, 22, 23, 24, 25, 26).
To our best knowledge this is the first study showing that C5a uses the intracellular signaling molecule SPHK1 as a key player in the physiological responses triggered by C5a in human macrophages. In this study we show that C5aR activation rapidly stimulates the production of S1P and SPHK activity. Moreover, knocking down the expression levels of SPHK1, with a specific antisense oligonucleotide, a number of the macrophage responses to C5a are inhibited, such as the C5a-stimulated intracellular Ca2+ signals, degranulation, cytokine production as well as cell migration. Thus, our data suggest that SPHK1 is indeed a key player in the proinflammatory responses triggered by human monocyte-derived macrophages stimulated by C5a.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
Isolation of human primary monocytes and differentiation to macrophages
Mononuclear cells were isolated from heparinized fasting venous blood by Ficoll-Hypaque centrifugation as previously described (27). The 20 ml of blood (anticoagulated with 10 U/ml heparin) was layered carefully on 15 ml of Ficoll-Hypaque gradient and centrifuged at 500 x g, without brakes at room temperature for 30 min. The mixed mononuclear band was aspirated and the cells were washed three times in phenol red RPMI 1640 medium containing 100 U/ml penicillin, 100 µg/ml streptomycin, and 2 mM glutamine and suspended in a known volume. Leukocyte count was performed on a Coulter counter and then cells were plated (5–7 x 106 cells) in six-well culture plates in RPMI 1640 medium. Incubation was conducted at 37°C for 2 h in 5% CO2/95% air, after which nonadherent cells were removed by washing the wells twice with RPMI 1640, and the remaining adherent cells were grown in the culture medium supplemented with 10% FCS and 2 mM glutamine. The medium was replaced every 2–3 days. The cells were used after 8 days of culture. Cell viability, determined by trypan blue exclusion, was >94% in all experiments.
SPHK activity in whole macrophages and generation of S1P
SPHK activity in intact cells was measured by assaying the amount of intracellular S1P generation following receptor activation as previously described (25, 28). Briefly, cells were preincubated overnight in medium containing [3H]serine (2 µCi/ml) to label cellular sphingolipids and free sphingosine pools. Following labeling, 2 x 106 cells/sample were stimulated by the addition of 5 nM C5a and warming to 37°C, and the reactions were terminated at the specified times. Lipids were extracted and analyzed by TLC on silica gel G60. Standard S1P was applied with the samples, and the lipids were visualized using iodine vapors. Bands corresponding to S1P were excised from the plate and counted by liquid scintillation spectrometry. Results were calculated as a percentage of the total radioactivity incorporated in the lipids.
SPHK activity in cell extracts
Human macrophages, 2 x 106 cells/sample, were stimulated by the addition of 5 nM C5a. Following C5a stimulation the cells are lysed and cell extracts are assayed for SPHK activity. SPHK activity was measured as previously described (24, 29). Briefly, the system is based upon the SPHK catalyzed transfer of the -phosphate group of ATP (using a mixture of cold ATP and [-32P]ATP (1 µCi/sample) to a specific substrate, the products were separated by TLC on silica gel G60 (Whatman, Maidstone, U.K.) and visualized by autoradiography. The radioactive spots corresponding to S1P were scraped and counted in a scintillation counter.
Phospholipase C (PLC) activity
Human macrophages, 2 x 106 cells/sample, were stimulated by the addition of 5 nM C5a. Following stimulation, inositol 1,4,5-triphosphate (IP3) was measured as previously described (24), using the BIOTRAK TRK 1000 kit (Amersham Biosciences, Buckinghamshire, U.K.).
Cytosolic calcium measurement
Cytosolic calcium was measured as previously described (24). Briefly, 2 x 106 cells/ml were loaded with 1 µg/ml fura 2-AM (Molecular Probes, Leiden, The Netherlands) in PBS, 1.5 mM Ca2+ and 1% BSA. After removal of excess reagents by dilution and centrifugation, the cells were resuspended in 1.5 mM Ca2+ supplemented PBS and warmed to 37°C in the cuvette. A total of 2 x 105 cells/sample were stimulated by the addition of 5 nM C5a. Fluorescence was measured at 340 and 380 nm and the background-corrected 340:380 ratio was calibrated as previously described (24).
Protein kinase C (PKC) activity
PKC enzyme activity was measured as previously stated (30, 31), using the Biotrak Protein Kinase C enzyme assay system (Amersham Biosciences). Briefly, the system is based upon the PKC catalyzed transfer of the -phosphate group of ATP (using a mixture of cold ATP and [-32P]ATP; 1 µCi/sample) to a peptide substrate specific for PKC. A total of 2 x 106 cells/sample were stimulated by the addition of 5 nM C5a for 15 min. Following stimulation, PKC assays were conducted. Results are expressed as phosphorylation rate per picomolar of protein per minute.
Degranulation and enzyme release
-Hexosaminidase is released from macrophages. Degranulation was measured using a previously described colorimetric assay to assess the release of -hexosaminidase (24). Briefly, 2 x 105 cells/sample were stimulated by the addition of 5 nM C5a for 30 min. Following stimulation, 50 µl of the sample supernatant was incubated with 200 µl of 1 mM p-nitrophenyl N-acetyl--D-glucosaminide for 1 h at 37°C. The total -hexosaminidase concentration was determined by a 1/1 extraction of the remaining buffer and cells with 1% Triton X-100; a 50 µl aliquot was removed and analyzed as described. The enzyme concentration was determined by measuring the OD at 400 nm.
Cytokine detection
A total of 2 x 106 cells/sample, pretreated or not with antisense oligos, were stimulated by the addition of 5 nM C5a for 24 h. Following stimulation, the supernatants were collected at the indicated time points and stored at –20°C until use. TNF-
, IL-6, and IL-8 levels in the supernatants were evaluated using ELISA (R&D Systems, Minneapolis, MN) following the manufacturer’s instructions.
Chemotaxis assay
Chemotaxis was assayed using the Chemicon QCM Chemotaxis 3 µm 96-well Cell Migration Assay kit (catalogue no. ECM 515; Temecula, CA) following manufacturers instructions. A total of 2 x 105 cells were used per sample and the concentration of C5a used for the migration assays was 5 nM.
RT-PCR analysis
mRNA from BMMC was isolated using the Qiagen midi kit for mRNA extraction. Specific forward (5'-TGAACCCGCGCGGCAAGGGC-3') and reverse (5'-GGTCAGCCGGCGCCATCCACG-3') primers were designed for the human SPHK1 to yield a 570 bp fragment, and specific forward (5'-CCATGGCGAG TTTGGCTCCT-3') and reverse (5'-CATCCC CGGGCAGTGG CAGTCCTCGG-3') primers were designed for the human SPHK2 to yield a 356 bp fragment.
Western blots
Unless stated other ways, 40 µg of lysate for each sample was resolved on 12% polyacrylamide gels (SDS-PAGE) under denaturing conditions and then transferred to 0.45-µm nitrocellulose membranes. After blocking overnight at 4°C with 5% nonfat milk in TBS, 0.1% Tween 20 and washing, the membranes were incubated with the relevant Abs for 4 h at room temperature. The membranes were washed extensively in TBS/0.1% Tween 20 (washing buffer). The blots were probed using specific, anti-SPHK1 polyclonal (made in house as previously described (21)), and a monoclonal anti-Arf1 (Santa Cruz Biotechnologies, Santa Cruz, CA), primary Abs. Bands were visualized using anti-rabbit HRP-conjugated, or anti-mouse HRP-conjugated, secondary Abs, and the ECL Western Blotting Detection System (Amersham Biosciences).
Fluorescent microscopy
After stimulation with 5 nM C5a, cells were fixed in 4% paraformaldehyde and deposited on microscope slides in a cytospin centrifuge, then permeabilized for 5 min in 0.1% Triton X-100 in PBS. Fluorescent labeling was performed using an anti-SPHK1 polyclonal Ab made by us as previously described (21). Staining was analyzed by fluorescence microscopy using a Leica DM IRB microscope, and images captured using a Leica DC 300F camera (Leica Microsystems, Bannockburn, IL).
Antisense knockdown of SPHK 1
The antisense down-regulation of SPHK1 was conducted as previously described (24). Antisense oligonucleotides were purchased from Oswell DNA Services (Southampton, U.K.); 20-mers were synthesized, capped at either end by the phosphorothiorate linkages (first two and last two linkages), and corresponded to the reverse complement of the first 20 coding nucleotides for SPHK1, and a scrambled oligo for control. The sequences of the oligonucleotides were: 5'-CCCGCAGGATCCATAACCTC-3' antisense for SPHK1; 5'-CTGGTGGAAGAAGAGGACGT-3' scrambled antisense for control. Cells were cultured in the presence of antisense for 48 h.
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We first investigated whether the C5aR would generate S1P and activate SPHK activity in the human macrophages. For this model, formation of [3H]S1P from [3H]sphingosine was first determined. Activation of the C5aR induced a rapid and transient increase in [3H]S1P generation (Fig. 1A), reaching its maximal [3H]S1P generation at 2 min. Parallel to the generation of S1P, direct measurement of SPHK activity showed that the enzyme is activated following C5aR engagement (Fig. 1B).
|
Two human SPHKs have recently been cloned and characterized, namely SPHK1 (32) and SPHK2 (33). First, the mRNA presence of specific SPHK isozymes present in the cells was examined; only the messenger for SPHK1 was found by RT-PCR in the human macrophages, and SKNMC were used as control (Fig. 2A). Fluorescent microscopy confirmed the presence of SPHK1, and showed that in resting cells SPHK1 is primarily cytosolic, but after C5aR engagement it rapidly translocates to the cell periphery (Fig. 2B, top).
|
80% as shown by Western blot analysis (Fig. 2C), whereas an antisense control (scrambled oligo) had no effect on the SPHK1 levels (Fig. 2C). In cells pretreated with the antisense oligo against SPHK1, C5a-stimulated formation of S1P was substantially inhibited (Fig. 2D). Direct measurement of SPHK activity was also inhibited in cells pretreated with the antisense against SPHK1 (Fig. 2E). However, pretreatment of the cells with a scrambled antisense oligonucleotide had no effect on S1P generation (Fig. 2D), nor on SPHK enzyme activity (Fig. 2E).
These data show that the C5aR is capable of stimulating SPHK activity and S1P generation by specifically activating SPHK1
Role of SPHK1 on C5a-triggered Ca2+ signals
Previous studies have demonstrated that SPHK mediates Ca2+ signals for several plasma membrane receptors (20, 21, 22, 23), and because our results showed that C5a triggers SPHK activity in human macrophages (Figs. 1 and 2), we decided to investigate the role of SPHK1 in the C5a-triggered Ca2+ mobilization in these cells. C5a stimulation rapidly and transiently triggered calcium release from internal stores (Fig. 3A). However, in cells pretreated with the antisense against SPHK1, these Ca2+ signals were inhibited (Fig. 3A). Pretreatment of the cells with the scrambled antisense oligonucleotide had no effect on the C5a-triggered Ca2+ signals (Fig. 3A).
|
Role of SPHK1 on C5a-triggered physiological responses
Following the role of SPHK1 on triggering Ca2+ signals, we investigated the role of SPHK1 in other well-characterized functional responses of macrophages following cellular activation by C5a, namely PKC activity, degranulation, cytokine release, and chemotaxis.
C5a-triggered PKC activity. PKC activity is important for many cellular responses, and most receptor trigger PKC activity. C5a triggered a fast increase of PKC enzyme activity in the macrophages (Fig. 4). Pretreatment with the antisense oligo against SPHK1 did not affect the PKC activity triggered by C5a, however, pretreatment with the PKC inhibitor, bisindolylmaleimide (Bis)I, indeed inhibited the PKC activity triggered by C5a (Fig. 4). This shows that SPHK1 does not play a role on the C5a-triggered activation of PKCs.
|
-hexosaminidase from the human macrophages (Fig. 5). Pretreatment of cells with the antisense oligo against SPHK1, substantially inhibited the C5a triggered enzyme release, whereas pretreatment with the scrambled antisense oligonucleotide had no effect on degranulation (Fig. 5). These results suggest a role for SPHK1 in regulating C5a-triggered degranulation.
|
|
and IL6 and IL8 release from the human macrophages (Fig. 7). However, in cells pretreated with the ansisense SPHK1 oligo, C5a-triggered release of TNF- (Fig. 7A), IL-6 (Fig. 7B), and IL-8 (Fig. 7C) was inhibited. In contrast pretreatment with the scramble antisense had no inhibitory effect on cytokine production, suggesting that SPHK1 mediates the C5a-triggered cytokine production on human macrophages.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
S1P has been shown to play an important role in immune cell activation including cytoskeletal changes and degranulation. We report for the first time that SPHK1 is rapidly activated by C5a in the human macrophages. Our data shows that SPHK1 is involved in the C5aR-mediated Ca2+ mobilization in human macrophages. Furthermore, knocking down SPHK1 levels, with the specific SPHK1 antisense oligonucleotides, substantially inhibited the C5a-triggered calcium release from internal stores, in a manner that was independent of the PLC/IP3 pathway because the antisense did not have any effect on the C5a-triggered IP3 generation.
To further investigate the physiological roles of the SPHK1 in the C5a signaling pathways, we studied the effects of the antisense knockdown of SPHK1 on PKC enzyme activity, degranulation, cytokine production, and chemotaxis. Many physiological responses triggered in phagocytic cells are dependent on the activation of PKC isoforms. Treatment of the macrophages with the antisense oligonucleotides against SPHK1, which caused a marked inhibition on the C5a-induced intracellular Ca2+ concentration signals, had no effect on the C5a-triggered stimulation of protein kinase activity, whereas the PKC inhibitor BisI did indeed inhibit PKC activation. These data suggest that SPHK is not involved in the signaling pathway to PKC activation. However, there is a tight correlation between increase of intracellular calcium and degranulation (23, 24, 26). Pretreatment of human macrophages with the antisense against SPHK1 strongly inhibited the C5a-triggered release of -hexosaminidase from the macrophages, indicating the requirement for SPHK1 in this response.
It is well established that C5a can trigger proinflammatory cytokines and chemokines, such as TNF-, IL-6, and IL-8 production (36, 37, 38, 39). These molecules share many activities, including the ability to induce fever and shock syndrome in animal models (47). In this report we show that C5a triggered the generation of TNF-, IL-6, and IL-8 to different levels. Moreover, pretreatment of cells with antisense against SPHK1 substantially inhibited the production of TNF-, IL-6, and IL-8 triggered by C5a. Inflammatory responses are characterized by the accumulation of macrophages at an inflammatory site. Where local inflammation is triggered by infection, trauma, or immune-complex deposition, C5a is likely to be an important chemokine. C5a has been shown to trigger chemotaxis in cell suspensions (48), and C5a-triggered cell migration has been used as a sensitive test for measuring the activation of the cell’s internal motile apparatus (49). In the present study we show that C5a is capable of triggering macrophage migration, and that pretreatment of cells with the antisense oligonucleotides against SPHK1 strongly inhibited the C5a-induced chemotaxis.
SPHK activity also plays a potential role in the physiological responses triggered on other immune-effector cells. Activated neutrophils generate a broad and a vigorous set of alterations in gene expression shaping the inflammatory response (50). It has been proposed that SPHK regulates neutrophil priming to provide an essential defense against infections (51), and in neutrophil inflammatory responses (26, 51). The recruitment of circulating neutrophils to damaged tissue plays a critical role in a number of physiological and pathophysiological events: circulating neutrophils attach to the activated endothelial cells in blood vessels through various adhesion molecules and then migrate through the endothelial cell layer into the injured sites; and SPHK activity has also been shown to modulate the expression of vascular cell adhesion molecules by endothelial cell (52), essential for the recruitment of leukocytes during the inflammatory response. Furthermore, it has been shown that TNF- and fMLP-stimulated superoxide production can be regulated by S1P and inhibited by the SPHK inhibitor DL-threo-dihydrosphingosine (53).
Another important role for SPHK activity has been proposed for mast cell activation. It has been suggested that the differential ratio sphingosine to S1P, in mast cells, regulates the activity of mast cells (54). Thus, mast cell activation triggered by the high-affinity IgE receptor (FcRI) leads to the activation of SPHK, which changes the balance of sphingosine toward S1P (54), and these two lipids have opposite effects. Although sphingosine inhibits the activation of members of the MAPK family, stress-activated protein kinase and AP-1, S1P activates these molecules, thereby inducing the proinflammatory action of mast cells, including the expression of TNF- and IL-5 genes products (54). Moreover, it has been shown that FcRI activates SPHK-dependent Ca2+ mobilization in mast cells (23, 24), as well as SPHK-dependent mast cell degranulation (24).
Phagocytic cell infiltration and proinflammatory cytokine production are universal components of a wide range of disease states including immune complex-mediated conditions such as nephritis (50), arthritis (51), and acute graft rejection (52). An agent that can inhibit phagocyte infiltration and/or the production of cytokines such as TNF- and IL-6 may have wide therapeutic applications in the prevention and treatment of these and other disease states. The present study indicates that knocking down the levels of SPHK1, with an antisense oligonucleotide, very effectively inhibits the cytokine production and chemotactic response triggered by the anaphylatoxin C5a in human macrophages. Our findings also indicate new pathways in the intracellular signaling cascades triggered by anaphylatoxins, and point out the role of novel molecules such as SPHK1, in immune-inflammatory processes, aiding the validation of novel potential "druggable targets" for the development of new therapeutics for inflammatory diseases.
|
Acknowledgments |
|---|
|
Footnotes |
|---|
1 This work was supported by a grant from the National Medical Research Council of Singapore (R-185-000-052-213). 
2 Address correspondence and reprint requests to Dr. Alirio J. Melendez, Department of Physiology, National University of Singapore, 2 Medical Drive, MD9 Room 01-05, 117597 Singapore. E-mail address: phsmraj{at}nus.edu.sg
3 Abbreviations used in this paper: GPCR, G protein-coupled receptor; SPHK, sphingosine kinase; DC, dendritic cell; S1P, sphingosine-1-phosphate; PLC, phospholipase C; PKC, protein kinase C; IP3, inositol 1,4,5-triphosphate; BisI, bisindolylmaleimide I.
Received for publication March 19, 2004. Accepted for publication May 20, 2004.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
RI antigen receptor. Nature 18:634.
RI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273:9393.-Tocopherol decreases CD36 expression in human monocyte-derived macrophages. J. Lipid Res. 42:521.RI antibody receptor to mobilize calcium. Curr. Biol. 8:210.[Medline]
RI, the human high-affinity receptor for immunoglobulin G. Immunology 96:457.[Medline]
in FcRI-mediated activation of phospholipase D1. Curr. Biol. 5:869.
and interleukin 1. J. Exp. Med. 168:443. induces adhesion molecule expression through the SPHK pathway. Proc. Natl. Acad. Sci. USA 95:14196.-mediated signal transduction in human neutrophils: involvement of sphingomyelin metabolites in the priming effect of TNF- on the fMLP-stimulated superoxide production. Life Sci. 66:245.[Medline]
receptor I triggering. J. Exp. Med. 190:1. on graft-versus-host disease and graft versus leukemia. J. Clin. Invest. 104:459.[Medline]Related articles in The JI:
This article has been cited by other articles:
|
|
 |
|
  M. M. Price, D. Kapitonov, J. Allegood, S. Milstien, C. A. Oskeritzian, and S. Spiegel Sphingosine-1-phosphate induces development of functionally mature chymase-expressing human mast cells from hematopoietic progenitors FASEB J, October 1, 2009; 23(10): 3506 - 3515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-Q. Lai, A. W. Irwan, H. H. Goh, A. J. Melendez, I. B. McInnes, and B. P. Leung Distinct Roles of Sphingosine Kinase 1 and 2 in Murine Collagen-Induced Arthritis J. Immunol., August 1, 2009; 183(3): 2097 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Pushparaj, H. K. Tay, C.-C. Wang, W. Hong, and A. J. Melendez VAMP8 Is Essential in Anaphylatoxin-Induced Degranulation, TNF-{alpha} Secretion, Peritonitis, and Systemic Inflammation J. Immunol., July 15, 2009; 183(2): 1413 - 1418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Dai, M. Jayapal, H. K. Tay, R. Reghunathan, G. Lin, C. T. Too, Y. T. Lim, S. H. Chan, D. M. Kemeny, R. A. Floto, et al. Differential signal transduction, membrane trafficking, and immune effector functions mediated by Fc{gamma}RI versus Fc{gamma}RIIa Blood, July 9, 2009; 114(2): 318 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Lai, A. W. Irwan, H. H. Goh, H. S. Howe, D. T. Yu, R. Valle-Onate, I. B. McInnes, A. J. Melendez, and B. P. Leung Anti-Inflammatory Effects of Sphingosine Kinase Modulation in Inflammatory Arthritis J. Immunol., December 1, 2008; 181(11): 8010 - 8017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tauseef, V. Kini, N. Knezevic, M. Brannan, R. Ramchandaran, H. Fyrst, J. Saba, S. M. Vogel, A. B. Malik, and D. Mehta Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial Cells Circ. Res., November 7, 2008; 103(10): 1164 - 1172. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-Q. Lai, H. H. Goh, Z. Bao, W. S. F. Wong, A. J. Melendez, and B. P. Leung The Role of Sphingosine Kinase in a Murine Model of Allergic Asthma J. Immunol., March 15, 2008; 180(6): 4323 - 4329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Kusner, C. R. Thompson, N. A. Melrose, S. M. Pitson, L. M. Obeid, and S. S. Iyer The Localization and Activity of Sphingosine Kinase 1 Are Coordinately Regulated with Actin Cytoskeletal Dynamics in Macrophages J. Biol. Chem., August 10, 2007; 282(32): 23147 - 23162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Kim, Y. Lee, E.-J. Chang, H.-M. Kim, S.-P. Hong, Z. H. Lee, J. Ryu, and H.-H. Kim Suppression of Osteoclastogenesis by N,N-Dimethyl-D-erythro-sphingosine: A Sphingosine Kinase Inhibition-Independent Action Mol. Pharmacol., August 1, 2007; 72(2): 418 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Landeen, N. Aroonsakool, J. H. Haga, B. S. Hu, and W. R. Giles Sphingosine-1-phosphate receptor expression in cardiac fibroblasts is modulated by in vitro culture conditions Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H2698 - H2711. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Brogdon, Y. Xu, S. J. Szabo, S. An, F. Buxton, D. Cohen, and Q. Huang Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function Blood, February 1, 2007; 109(3): 1123 - 1130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Edwards, X. Zhang, K. A. Frauwirth, and D. M. Mosser Biochemical and functional characterization of three activated macrophage populations J. Leukoc. Biol., December 1, 2006; 80(6): 1298 - 1307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Zhang, J. C. Fehrenbacher, M. R. Vasko, and G. D. Nicol Sphingosine-1-Phosphate Via Activation of a G-Protein-Coupled Receptor(s) Enhances the Excitability of Rat Sensory Neurons J Neurophysiol, September 1, 2006; 96(3): 1042 - 1052. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. W. Wattenberg, S. M. Pitson, and D. M. Raben The sphingosine and diacylglycerol kinase superfamily of signaling kinases: localization as a key to signaling function J. Lipid Res., June 1, 2006; 47(6): 1128 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yadav, L. Clark, and J. S. Schorey Macrophage's Proinflammatory Response to a Mycobacterial Infection Is Dependent on Sphingosine Kinase-Mediated Activation of Phosphatidylinositol Phospholipase C, Protein Kinase C, ERK1/2, and Phosphatidylinositol 3-Kinase J. Immunol., May 1, 2006; 176(9): 5494 - 5503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Sutherland, P. A. B. Moretti, N. M. Hewitt, C. J. Bagley, M. A. Vadas, and S. M. Pitson The Calmodulin-binding Site of Sphingosine Kinase and Its Role in Agonist-dependent Translocation of Sphingosine Kinase 1 to the Plasma Membrane J. Biol. Chem., April 28, 2006; 281(17): 11693 - 11701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Wesselkamper, S. A. McDowell, M. Medvedovic, T. P. Dalton, H. S. Deshmukh, M. A. Sartor, L. M. Case, L. N. Henning, M. T. Borchers, C. R. Tomlinson, et al. The Role of Metallothionein in the Pathogenesis of Acute Lung Injury Am. J. Respir. Cell Mol. Biol., January 1, 2006; 34(1): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. C. Hait, S. Sarkar, H. Le Stunff, A. Mikami, M. Maceyka, S. Milstien, and S. Spiegel Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor J. Biol. Chem., August 19, 2005; 280(33): 29462 - 29469. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. P. Vlasenko and A. J. Melendez A Critical Role for Sphingosine Kinase in Anaphylatoxin-Induced Neutropenia, Peritonitis, and Cytokine Production in Vivo J. Immunol., May 15, 2005; 174(10): 6456 - 6461. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Thompson, S. S. Iyer, N. Melrose, R. VanOosten, K. Johnson, S. M. Pitson, L. M. Obeid, and D. J. Kusner Sphingosine Kinase 1 (SK1) Is Recruited to Nascent Phagosomes in Human Macrophages: Inhibition of SK1 Translocation by Mycobacterium tuberculosis J. Immunol., March 15, 2005; 174(6): 3551 - 3561. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
); PKC activity after C5a stimulation in untreated cells (Cells control, 
); basal PKC activity in the cells pretreated with the SPHK1 antisense (Cells+a.s.SPHK1, 
